E Fund Management Co., Ltd. - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$420
-5.2%
17,470
+26.0%
0.03%
-8.6%
Q2 2023$443
+20.4%
13,867
+15.4%
0.04%
+29.6%
Q1 2023$368
-6.1%
12,016
+19.7%
0.03%
-18.2%
Q4 2022$392
-99.9%
10,035
+21.2%
0.03%
-10.8%
Q3 2022$395,000
-22.9%
8,283
-37.4%
0.04%
-19.6%
Q2 2022$512,000
+103.2%
13,237
+200.6%
0.05%
+475.0%
Q1 2022$252,0004,4040.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders